PharmaSGP Holding Balance Sheet Health
Financial Health criteria checks 3/6
PharmaSGP Holding has a total shareholder equity of €39.8M and total debt of €73.1M, which brings its debt-to-equity ratio to 183.8%. Its total assets and total liabilities are €131.3M and €91.5M respectively. PharmaSGP Holding's EBIT is €24.7M making its interest coverage ratio 5.9. It has cash and short-term investments of €40.8M.
Key information
183.8%
Debt to equity ratio
€73.08m
Debt
| Interest coverage ratio | 5.9x |
| Cash | €40.77m |
| Equity | €39.75m |
| Total liabilities | €91.55m |
| Total assets | €131.30m |
Recent financial health updates
No updates
Recent updates
Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings
May 06
Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio
Mar 02PharmaSGP Holding SE Just Beat Revenue Estimates By 25%
Dec 02One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically
Feb 16
We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential
Jan 26Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?
Dec 04Financial Position Analysis
Short Term Liabilities: PSG's short term assets (€62.8M) exceed its short term liabilities (€24.6M).
Long Term Liabilities: PSG's short term assets (€62.8M) do not cover its long term liabilities (€67.0M).
Debt to Equity History and Analysis
Debt Level: PSG's net debt to equity ratio (81.3%) is considered high.
Reducing Debt: PSG's debt to equity ratio has increased from 0% to 183.8% over the past 5 years.
Debt Coverage: PSG's debt is well covered by operating cash flow (36.5%).
Interest Coverage: PSG's interest payments on its debt are well covered by EBIT (5.9x coverage).